Efficacité osseuse du raloxifène : au-delà des chiffresLEGRAND, Erick.Revue du rhumatisme (Ed. française). 2004, Vol 71, pp 6-10, issn 1169-8330, 5 p., HS1Article

Bone cell-independent benefits of raloxifene on the skeleton: A novel mechanism for improving bone material propertiesGALLANT, Maxime A; BROWN, Drew M; HAMMOND, Max et al.Bone (New York, NY). 2014, Vol 61, pp 191-200, issn 8756-3282, 10 p.Article

Estrogen alone or combined with medroxyprogesterone but not raloxifene reduce myocardial infarct sizeSBAROUNI, Eftihia; ILIODROMITIS, Efstathios K; BOFILIS, Elias et al.European journal of pharmacology. 2003, Vol 467, Num 1-3, pp 163-168, issn 0014-2999, 6 p.Article

Review on raloxifene: profile of a selective estrogen receptor modulatorHERINGA, M.International journal of clinical pharmacology and therapeutics. 2003, Vol 41, Num 8, pp 331-345, issn 0946-1965, 15 p.Article

The effect of cessation of raloxifene treatment on bone turnover in postmenopausal womenNAYLOR, K. E; CLOWES, J. A; FINIGAN, J et al.Bone (New York, NY). 2010, Vol 46, Num 3, pp 592-597, issn 8756-3282, 6 p.Article

DT56a stimulates gender-specific human cultured bone cells in vitroSOMJEN, Dalia; KATZBURG, Sara; LIEBERHERR, M et al.Journal of steroid biochemistry and molecular biology. 2006, Vol 98, Num 1, pp 90-96, issn 0960-0760, 7 p.Article

Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone ClubBODY, J.-J; BERGMANN, P; BOONEN, S et al.Osteoporosis international. 2010, Vol 21, Num 10, pp 1657-1680, issn 0937-941X, 24 p.Article

Effects of raloxifene on mood, sleep, libido and cognitive function in postmenopausal healthy women: a pilot studyNATALE, Vincenzo; ALBERTAZZI, Paola; MISSIROLI, Natalie et al.Maturitas (Amsterdam). 2004, Vol 48, Num 1, pp 59-63, issn 0378-5122, 5 p.Article

Effects of raloxifene and alendronate on bone turnover as assessed by procollagen type I N-terminal propeptideEASTELL, R; ROGERS, A; NI, X et al.Osteoporosis international. 2011, Vol 22, Num 6, pp 1927-1934, issn 0937-941X, 8 p.Article

Risk of femoral shaft and subtrochanteric fractures among users of bisphosphonates and raloxifeneVESTERGAARD, P; SCHWARTZ, F; REJNMARK, L et al.Osteoporosis international. 2011, Vol 22, Num 3, pp 993-1001, issn 0937-941X, 9 p.Article

A meta-analysis of the efficacy of raloxifene on all clinical and vertebral fractures and its dependency on FRAX®RANIS, John A; JOHANSSON, Helena; ODEN, Anders et al.Bone (New York, NY). 2010, Vol 47, Num 4, pp 729-735, issn 8756-3282, 7 p.Article

Comparing therapies for postmenopausal osteoporosis prevention and treatmentEICHNER, Samantha F; LLOYD, Kimberly B; TIMPE, Erin M et al.The Annals of pharmacotherapy. 2003, Vol 37, Num 5, pp 711-724, issn 1060-0280, 14 p.Article

Compliance and satisfaction with raloxifene versus alendronate for the treatment of postmenopausal osteoporosis in clinical practice: An open-label, prospective, nonrandomized, observational studyTURBI, Carmen; HERRERO-BEAUMONT, Gabriel; ACEBES, Juan Carlos et al.Clinical therapeutics. 2004, Vol 26, Num 2, pp 245-256, issn 0149-2918, 12 p.Article

Le raloxifène : un modulateur sélectif du récepteur aux oestrogènes = Raloxifen : a selective estrogen receptor moulatorVAN DEN BRULE, F. A; KALBUS, M.-F; GASPARD, U. J et al.Journal de gynécologie obstétrique et biologie de la reproduction. 1999, Vol 28, Num 8, pp 788-799, issn 0368-2315Article

Les nouvelles molécules estrogéniques = New estrogen moleculesDEGRELLE, H.Reproduction humaine et hormones. 1999, Vol 12, Num 4, pp 327-332, issn 0994-3919Conference Paper

Raloxifene for prevention of glucocorticoid-induced bone loss: a 12-month randomised double-blinded placebo-controlled trialCHI CHIU MOK; KING YEE YING; CHI HUNG TO et al.Annals of the rheumatic diseases. 2011, Vol 70, Num 5, pp 778-784, issn 0003-4967, 7 p.Article

Safety and adverse effects associated with raloxifene: Multiple Outcomes of Raloxifene EvaluationGRADY, Deborah; ETTINGER, Bruce; MOSCARELLI, Elena et al.Obstetrics and gynecology (New York. 1953). 2004, Vol 104, Num 4, pp 837-844, issn 0029-7844, 8 p.Article

Environmental fate and chemistry of raloxifene hydrochlorideTEETER, Jerold Scott; MEYERHOFF, Roger D.Environmental toxicology and chemistry. 2002, Vol 21, Num 4, pp 729-736, issn 0730-7268Article

Place des serm (selective estrogen receptor modulators) dans la substitution hormonale postménopausique = Place of serms (selective estrogen receptor modulators) for hormone replacement therapy in postmenopausal womenWIRTHNER, D; DE GRANDI, P.Médecine et hygiène. 2000, Vol 58, Num 2312, pp 1677-1681, issn 0025-6749, 4 p.Article

Characterization of hot flashes reported by healthy postmenopausal women receiving raloxifene or placebo during osteoporosis prevention trialsCOHEN, F. J; YILI LU.Maturitas (Amsterdam). 2000, Vol 34, Num 1, pp 65-73, issn 0378-5122Article

Les modulateurs spécifiques des récepteurs oestrogéniques (SERMs) : Nouvelles thérapeutiques en gynécologie = Specific estrogen receptor modulators (SERMs) : New therapeutics in gynecologyTREMOLLIERES, Florence; LOPES, Patrice.La Presse médicale (1983). 2002, Vol 31, Num 28, pp 1323-1328, issn 0755-4982, 6 p.Article

Role of nociceptor estrogen receptor GPR30 in a rat model of endometriosis painALVAREZ, Pedro; BOGEN, Oliver; LEVINE, Jon D et al.Pain (Amsterdam). 2014, Vol 155, Num 12, pp 2680-2686, issn 0304-3959, 7 p.Article

Combination treatment with eldecalcitol (ED-71) and raloxifene improves bone mechanical strength by suppressing bone turnover and increasing bone mineral density in ovariectomized ratsTAKEDA, Satoshi; SAKAI, Sadaoki; SHIRAISHI, Ayako et al.Bone (New York, NY). 2013, Vol 53, Num 1, pp 167-173, issn 8756-3282, 7 p.Article

Effects of raloxifene treatment on the structural geometry of the proximal femur in Japanese women with osteoporosisTAKADA, Junichi; MIKI, Takami; IMANISHI, Yasuo et al.Journal of bone and mineral metabolism (English ed.). 2010, Vol 28, Num 5, pp 561-567, issn 0914-8779, 7 p.Article

Lipid, glucose and homocysteine metabolism in women treated with a GnRH agonist with or without raloxifenePALOMBA, Stefano; RUSSO, Tiziana; ORIO, Francesco JR et al.Human reproduction (Oxford. Print). 2004, Vol 19, Num 2, pp 415-421, issn 0268-1161, 7 p.Article